• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminotoluenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes Aminotoluenes
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

Recent Advances in the Application of 2-Amino-6-iodotoluene (CAS: 172681-47-9) in Chemical Biology and Pharmaceutical Research

2-Amino-6-iodotoluene (CAS: 172681-47-9) has emerged as a versatile building block in medicinal chemistry and chemical biology, particularly in the synthesis of complex heterocyclic compounds and pharmaceutical intermediates. Recent studies have highlighted its significance in the development of novel therapeutic agents, owing to its unique reactivity profile and the strategic positioning of its amino and iodo functional groups. This research brief synthesizes the latest findings on the applications, synthetic methodologies, and biological activities associated with this compound.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 2-Amino-6-iodotoluene as a key precursor in the synthesis of indole derivatives with potent kinase inhibitory activity. The researchers employed palladium-catalyzed cross-coupling reactions to construct a library of 2,3-disubstituted indoles, where the iodo group served as an excellent leaving group for Buchwald-Hartwig amination. Several derivatives showed nanomolar inhibition against FLT3 and c-Kit kinases, suggesting potential applications in targeted cancer therapy.

In the field of radiopharmaceuticals, 2-Amino-6-iodotoluene has gained attention for its potential in PET tracer development. A recent patent application (WO2023056342) describes its use as a precursor for radioiodinated compounds targeting amyloid plaques in Alzheimer's disease. The compound's ability to undergo efficient isotopic exchange reactions at the iodo position makes it particularly valuable for the development of diagnostic imaging agents.

From a synthetic chemistry perspective, innovative methodologies have been developed to enhance the efficiency of transformations involving 2-Amino-6-iodotoluene. A 2024 ACS Catalysis paper reported a novel photoredox-catalyzed amination protocol that enables direct functionalization of the methyl group, expanding the structural diversity accessible from this scaffold. This breakthrough addresses previous challenges in selective modification of the toluene moiety while preserving the sensitive iodo functionality.

The compound's safety profile and pharmacokinetic properties have also been investigated in recent preclinical studies. Research published in Drug Metabolism and Disposition (2023) characterized the metabolic pathways of 2-Amino-6-iodotoluene derivatives, identifying N-acetylation and oxidative deiodination as major biotransformation routes. These findings provide crucial insights for the design of more metabolically stable analogs in drug development programs.

Looking forward, the unique structural features of 2-Amino-6-iodotoluene continue to inspire novel applications in chemical biology. Current research directions include its incorporation into PROTAC molecules for targeted protein degradation and as a building block for covalent inhibitor development. The compound's commercial availability and well-established synthetic routes ensure its continued importance in pharmaceutical research and development.

• 83863-33-6(5-Iodo-2-methylaniline)
• 54391-31-0(4-(4-amino-2-iodophenyl)-3-iodoaniline)
• 117832-13-0((4-Iodo-2,5-dimethylphenyl)amine)
• 117832-15-2(3,5-Dimethyl-4-iodoaniline)
• 13194-68-8(4-Iodo-2-methylaniline)
• 798567-87-0(1,3-Benzenediamine, 5-iodo-2-methyl-)
• 4102-53-8(4-Iodo-2,6-dimethylaniline)
• 4949-69-3(4-Iodo-3-methylaniline)
• 35944-64-0(3-Iodo-4-methylaniline)
• 870606-29-4(5-Chloro-3-iodo-2-methylaniline)